ELVN
Enliven Therapeutics, Inc.
$51.73
+0.86 (+1.69%)
At close · Jul 14
Market Cap
$3.24B
Shares
60,904,946
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-06-23 | $200,000,000 | $200,000,000 | 2026-03-31 | — | 10-Q , filed 2026-05-07 |
Key facts
CIK
1672619
CUSIP
29337E102
13F (30d)
11 filings
10 filers
Visit website
Investor relations